Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 11/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 10/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15794108 | 0.79 | SLC6A4 (0.97) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL14090989 | 0.78 | SLC6A4 (0.71) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL2070575 | 0.77 | SLC6A4 (0.41) | SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL2070640 | 0.76 | SLC6A4 (0.46) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL14962107 | 0.75 | SLC6A2 (0.65) | SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL5582525 | 0.75 | — | — | |
| SCHEMBL22778230 | 0.68 | HTR3A (0.73) | SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL4479313 | 0.68 | SLC6A4 (0.40) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL1866266 | 0.68 | SLC6A2 (0.49) | SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL970753 | 0.67 | SLC6A2 (0.51) | SLC6A4SLC6A2SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902367-B2 | Cyclic amino benzoic acid derivative | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20070249580-A1 | Novel Cyclic Amino Benzoic Acid Derivative | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2007-10-25 | — | — | US | disclosed |
| EP-1780210-A1 | NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE | Kyorin Pharmaceutical Co., Ltd. (JP) | 2007-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249580-A1 | Novel Cyclic Amino Benzoic Acid Derivative | PPARA, PPARG, PPARD | SLC6A4 1813/4885SLC6A2 2893/4885SLC6A3 2049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.